Because IL-33 is expressed in epithelial cells of the skin and pancreas during chronic inflammation, statin’s efficacy in cancer suppression may be related to its ability to block nuclear and cytokine functions of IL-33 in cancer-initiating epithelial cells. Here, IL33 is linked to cancer.